Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

166 results about "Test pulse" patented technology

The pulse test’s effectiveness is based on the observation that energy toxins accelerate the pulse rate. An individual's radial pulse can be measured from the wrist. The average pulse of an infant is 100 to 160 beats per minute. A person's pulse can be affected by the presence of thyroid disorders.

Lead condition assessment for an implantable medical device

A method, system, and apparatus for performing a lead condition assessment and / or a lead orientation determination associated with an implantable medical device (IMD). A first impedance is determined. The first impedance relates to the impedance relative to a first electrode and a portion of the IMD. A second impedance is determined. The second impedance relates to the impedance relative to a second electrode and the portion of the IMD. The first impedance is compared with the second impedance to determine an impedance difference. A determination is made whether the impedance difference is outside a predetermined tolerance range. Furthermore, artifact measured during impedance measurements or test pulses may be compared to assess lead orientation. An indication of a lead condition error is provided in response to determining that the impedance difference is outside the predetermined tolerance range.
Owner:LIVANOVA USA INC

Dynamic real-time evaluation equipment for irreversible electroporation tissue ablation

InactiveCN109157280AAvoid stabilityAvoid problems reflecting limited ablation areaSurgical instruments for heatingMathematical modelDynamic monitoring
The invention discloses dynamic real-time evaluation equipment for irreversible electroporation tissue ablation, which utilizes an electrode in an irreversible electroporation tumor treatment primarypulse application process to detect tissue impedance spectrum changes before and after pulse treatment. As that instability of the impedance spectrum signal measure by the applied pulse electrode andthe problem of reflect the limited ablation area are effectively avoided, the relationship between the impedance spectrum measured by different electrode pairs and the actual ablation size is established aft subsequent data processing according to the impedance spectrum variation measured by different electrode pairs. At the same time, the change of tissue electrical properties was obtained by applying small signal test pulse during the treatment, and the mathematical model was established to judge the tissue ablation condition. At that same time, the invention can combine the advantage of thesweep frequency method and the test pulse method respectively, and solve the important problem of dynamic monitoring of curative effect in the treatment process of ablation effect aft irreversible electroporation pulse treatment and immediate evaluation of curative effect after treatment.
Owner:CHONGQING UNIV

Method for detecting and treating insulation lead-to-housing failures

Disclosed is a method for the diagnosis of conductor anomalies, such as an insulation failure resulting in a short circuit, in an implantable medical device, such as an implantable cardioverter defibrillator (ICD). Upon determining if a specific defibrillation pathway is shorted, the method excludes the one electrode from the defibrillation circuit, delivering defibrillation current only between functioning defibrillation electrodes. Protection can be provided against a short in the right-ventricular coil-CAN defibrillation pathway of a pectoral, transvenous ICD with a dual-coil defibrillation lead. If a short caused by an in-pocket abrasion is present, the CAN is excluded from the defibrillation circuit, delivering defibrillation current only between the right-ventricular and superior vena cava defibrillation coils. Determination that the defibrillation pathway is shorted may be made by conventional low current measurements or delivery of high current extremely short test pulses.
Owner:LAMBDA NU TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products